Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer
Mirco Pistelli(Ospedali Riuniti Umberto I), Stefano Cascinu(Vita-Salute San Raffaele University)
Cited by 4
Related Papers
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
|Journal of Clinical Oncology|2002|416
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
|Journal of Clinical Oncology|1994|200
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
|Journal of Clinical Oncology|2015|181